Indeed, SOX4 transcription factor, a member of the SOX (SRY-related HMG-box) family, has been shown to promote EMT in vitro, while SOX4 overexpression in tumor tissue indicated poor prognosis in patients with iCCA [86]. The gene discussed is SOX4; the disease is neoplasm.